Stockreport

Cardiff Oncology to Participate in Two Upcoming Investor Conferences

Cardiff Oncology, Inc.  (CRDF) 
PDF SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel [Read more]